Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: Relevance for human exposures

Reproductive Toxicology

Volumn 45, Issue , 2014, Pages 105-116

  Vom Saal, Frederick S ^a   Vandevoort, Catherine A ^b,c   Taylor, Julia A ^a   Welshons, Wade V ^a   Toutain, Pierre Louis ^d,e   Hunt, Patricia A ^f  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^f WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Bisphenol A; Fetus; Maternal; Pharmacokinetics; Pregnancy; Rhesus monkey

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; SILASTIC; BAYSILON; BENZHYDRYL DERIVATIVE; DIMETICONE; ESTROGEN; MICROCAPSULE; PHENOL DERIVATIVE;

ADULT; AMNION FLUID; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DECIDUA; FEMALE; FETUS BLOOD; FIRST TRIMESTER PREGNANCY; HALF LIFE TIME; MATERNAL SERUM; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PERINATAL DRUG EXPOSURE; PHARMACOKINETICS; PREGNANCY; RHESUS MONKEY; THIRD TRIMESTER PREGNANCY; ANIMAL; BLOOD; CHEMISTRY; ENVIRONMENTAL EXPOSURE; FETOMATERNAL TRANSFUSION; HUMAN; METABOLISM; MICROCAPSULE; ORAL DRUG ADMINISTRATION;

MACACA MULATTA;

ADMINISTRATION, ORAL; ANIMALS; BENZHYDRYL COMPOUNDS; CAPSULES; DIMETHYLPOLYSILOXANES; ENVIRONMENTAL EXPOSURE; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; MACACA MULATTA; MATERNAL-FETAL EXCHANGE; PHENOLS; PREGNANCY;

EID: 84900455846     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2014.01.007     Document Type: Article

References (56)

1. Stahlhut R.W., Welshons W.V., Swan S.H. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ. Health Perspect. 2009, 117:784-789.
2. Taylor J.A., Vom Saal F.S., Welshons W.V., Drury B., Rottinghaus G., Hunt P.A., et al. Similarity of bisphenol a pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ. Health Perspect. 2011, 119:422-430.
3. Vandenberg L.N., Chahoud I., Heindel J.J., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 2010, 118:1055-1070.
4. Dekant W., Volkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 2008, 228:114-134.
5. EnvironmentCanada. Screening assessment for the challenge phenol, 4,4'-(1-methylethylidene)bis-(Bisphenol A). Chemical Abstracts Service Registry Number 80-05-7. Environment Canada and Health Canada, Ottawa; October 2008.
6. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ. Health Perspect. 2008, 116:39-44.
7. Cao X.L., Zhang J., Goodyer C.G., Hayward S., Cooke G.M., Curran I.H. Bisphenol A in human placental and fetal liver tissues collected from Greater Montreal area (Quebec) during 1998-2008. Chemosphere 2012, 505-511.
8. Schonfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in human maternal-fetal-placental unit. Environ Health Perspect 2002, 110:A703-A707.
9. Corbel T., Gayrard V., Viguie C., Puel S., Lacroix M.Z., Toutain P.L., et al. Bisphenol A disposition in the sheep maternal-placental-fetal unit: mechanisms determining fetal internal exposure. Biol Reprod 2013, 89(1):11.
10. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009, 30:75-95.
11. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147:S56-S69.
12. vom Saal F.S., Akingbemi B.T., Belcher S.M., Birnbaum L.S., Crain D.A., Eriksen M., et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 2007, 24:131-138.
13. Rubin B.S., Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011, 127:27-34.
14. Angle B.M., Do R.P., Ponzi D., Stahlhut R.W., Drury B.E., Nagel S.C., et al. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): Evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod Toxicol 2013, 42:256-268.
15. Prins G.S., Ye S.H., Birch L., Ho S.M., Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Reprod Toxicol 2011, 31:1-9.
16. Rochester J.R. Bisphenol A and human health: A review of the literature. Reprod Toxicol 2013, 42:132-155.
17. Braun J.M., Hauser R. Bisphenol A and children's health. Curr Opin Pediatr 2011, 23:233-239.
18. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 2007, 24:199-224.
19. ANSES. French Agency for Food, Environmental and Occupational Health & Safety. Health Effects of Bisphenol A (Request nos. 2009-SA-0331 and 2010-SA-0197; September 2011). Accessed: December 30, 2011; 2011. http://www.anses.fr/index.htm.
20. Gayrard V., Lacroix M.Z., Collet S.H., Viguie C., Bousquet-Melou A., Toutain P.L., et al. High bioavailability of bisphenol a from sublingual exposure. Environ Health Perspect 2013, 121:951-956.
21. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007, 24:139-177.
22. Gies A., Heinzow B., Dieter H.H., Heindel J. Bisphenol a workshop of the German Federal Environment Agency-March 30-31, 2009 work group report: public health issues of bisphenol A. Int J Hygiene Environ Health 2009, 212:693-696.
23. Sieli P.T., Jasarevic E., Warzak D.A., Mao J., Ellersieck M.R., Liao C., et al. Comparison of serum bisphenol A concentrations in mice exposed to bisphenol A through the diet versus oral bolus exposure. Environ Health Perspect 2011, 119:1260-1265.
24. Vandenberg L.N., Chahoud I., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ Health Perspect 2010, 118:1051-1054.
25. Biedermann S., Tschudin P., Grob K. Transfer of bisphenol A from thermal printer paper to the skin. Anal Bioanal Chem 2010, 398:571-576.
26. Zalko D., Jacques C., Duplan H., Bruel S., Perdu E. Viable skin efficiently absorbs and metabolizes bisphenol A. Chemosphere 2011, 82:424-430.
27. Rudel R.A., Brody J.G., Spengler J.D., Vallarino J., Geno P.W., Sun G., et al. Identification of selected hormonally active agents and animal mammary carcinogens in commercial and residential air and dust samples. J Air Waste Manage Assoc. (1995) 2001, 51:499-513.
28. Geens T., Roosens L., Neels H., Covaci A. Assessment of human exposure to Bisphenol-A, Triclosan and Tetrabromobisphenol-A through indoor dust intake in Belgium. Chemosphere 2009, 76:755-760.
29. Loganathan S.N., Kannan K. Occurrence of bisphenol a in indoor dust from two locations in the eastern United States and implications for human exposures. Arch Environ Contam Toxicol 2012, 61:68-73.
30. Duty S.M., Mendonca K., Hauser R., Calafat A.M., Ye X., Meeker J.D., et al. Potential sources of bisphenol A in the neonatal intensive care unit. Pediatrics 2013, 131:483-489.
31. Hunt P.A., Lawson C., Gieske M., Murdoch B., Smith H., Marre A., et al. Bisphenol A alters early oogenesis and follicle formation in the fetal ovary of the rhesus monkey. Proc Natl Acad Sci U S A 2012, 109:17525-17530.
32. Elsworth J.D., Jentsch J.D., Vandevoort C.A., Roth R.H., D.E., Leranth C. Prenatal exposure to bisphenol A impacts midbrain dopamine neurons and hippocampal spine synapses in non-human primates. Neurotoxicology 2013, 35:113-120.
33. Tharp A.P., Maffini M.V., Hunt P.A., Vandevoort C.A., Sonnenschein C., Soto A.M. Bisphenol A alters the development of the rhesus monkey mammary gland. Proc Natl Acad Sci U S A 2012, 109:8190-8195.
34. Van Winkle L.S., Murphy S.R., Boetticher M.V., Vandevoort C.A. Fetal exposure of rhesus macaques to bisphenol a alters cellular development of the conducting airway by changing epithelial secretory product expression. Environ Health Perspect 2013, 121:912-918.
35. Liao C., Kannan K. Determination of free and conjugated forms of bisphenol a in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ Sci Technol 2012, 46:5003-5009.
36. Gerona R.R., Woodruff T.J., Dickenson C.A., Pan J., Schwartz J.M., Sen S., et al. BPA, BPA glucuronide, and BPA sulfate in mid-gestation umbilical cord serum in a northern California cohort. Environ Sci Technol 2013, 47:12477-12485.
37. Tarantal A.F. Ultrasound imaging in rhesus (Macaca mulatta) and long-tailed (Macaca fascicularis) macaques: reproductive and research applications. The Laboratory Primate 2005, 317-351. Elsevier Academic Press, Boston. S. Wolfe-Coote (Ed.).
38. Ye X., Zhou X., Hennings R., Kramer J., Calafat A.M. Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitoring analysis: an elusive laboratory challenge. Environ Health Perspect 2013, 121:283-286.
39. Padmanabhan V., Siefert K., Ransom S., Johnson T., Pinkerton J., Anderson L., et al. Maternal bisphenol-A levels at delivery: a looming problem?. J Perinatol 2008, 28:258-263.
40. Gibaldi M., Perrier D. Pharmacokinetics 1982, Marcel Dekker, New York. 2nd ed.
41. Slikker W., Bailey J.R., Newport D., Lipe G.W., Hill D.E. Placental transfer and metabolism of 17 alpha-ethynylestradiol-17 beta and estradiol-17 beta in the rhesus monkey. J Pharmacol Exp Ther 1982, 223:483-489.
42. Patterson T.A., Twaddle N.C., Roegge C.S., Callicott R.J., Fisher J.W., Doerge D.R. Concurrent determination of bisphenol A pharmacokinetics in maternal and fetal rhesus monkeys. Toxicol Appl Pharmacol 2013, 267:41-48.
43. Horan C. Physiological changes in pregnancy. Obstetric evidence based guidelines 2007, Informa, London. 1st ed. V. Berghella (Ed.).
44. Silversides C.K., Colman J.M. Physiological changes in pregnancy. Heart disease in pregnancy 2007, 6-17. Blackwell Publishing, Malden, Massachusetts. 2nd ed. C. Oakley, C.A. Warnes (Eds.).
45. Domoradzki J.Y., Pottenger L.H., Thornton C.M., Hansen S.C., Card T.L., Markham D.A., et al. Metabolism and pharmacokinetics of bisphenol A (BPA) and the embryo-fetal distribution of BPA and BPA-monoglucuronide in CD Sprague-Dawley rats at three gestational stages. Toxicol Sci 2003, 76:21-34.
46. Doerge D.R., Twaddle N.C., Woodling K.A., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys. Toxicol Appl Pharmacol 2010, 248:1-11.
47. Davison J.M., Noble M.C. Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. Br J Obstet Gynaecol 1981, 88:10-17.
48. Boxenbaum H. Pharmacokinetics tricks and traps: flip-flop models. J Pharm Pharm Sci 1998, 1:90-91.
49. Nishikawa M., Iwano H., Yanagisawa R., Koike N., Inoue H., Yokota H. Placental transfer of conjugated bisphenol A and subsequent reactivation in the rat fetus. Environ Health Perspect 2010, 118:1196-1203.
50. Taylor J.A., Welshons W.V., Vom Saal F.S. No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24h after administration in neonatal female mice. Reprod Toxicol 2008, 25:169-176.
51. de Wildt S.N., Kearns G.L., Leeder J.S., van den Anker J.N. Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet. 1999, 36:439-452.
52. Pasqualini J.R. Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol 2005, 97:401-415.
53. Vinas R., Watson C.S. Mixtures of xenoestrogens disrupt estradiol-induced non-genomic signaling and downstream functions in pituitary cells. Environ Health: A Glob Access Sci Sour 2013, 12:26.
54. Volkel W., Colnot T., Csanady G.A., Filser J.G., Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol 2002, 15:1281-1287.
55. Mendum T., Stoler E., Vanbenschoten H., Warner J.C. Concentration of bisphenol A in thermal paper. Green Chem Lett Rev 2011, 4:81-86.
56. Liao C., Kannan K. Widespread occurrence of bisphenol A in paper and paper products: implications for human exposure. Environ Sci Technol 2011, 45:9372-9739.